Crinetics Pharmaceuticals Stock Options Expiring on 16th of January 2026
| CRNX Stock | USD 57.20 0.47 0.81% |
Crinetics Pharmaceuticals' latest option contracts expiring on 2026-01-16 are carrying combined implied volatility of 0.39 with a put-to-call open interest ratio of 0.0 over 8 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2026-01-16. The total put volume is at 1.0, with calls trading at the volume of 1.0. This yields a 0.06 put-to-call volume ratio.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crinetics Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. Crinetics Pharmaceuticals In The Money Call Balance
When Crinetics Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Crinetics Pharmaceuticals stock is said to be in the money. When it comes to buying Crinetics Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Crinetics Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Crinetics Current Options Market Mood
Crinetics Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Crinetics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Crinetics Pharmaceuticals' options investors are not very successful. Crinetics Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Crinetics contract
Base on the Rule 16, the options market is currently suggesting that Crinetics Pharmaceuticals will have an average daily up or down price movement of about 0.0244% per day over the life of the 2026-01-16 option contract. With Crinetics Pharmaceuticals trading at USD 57.2, that is roughly USD 0.0139. If you think that the market is fully incorporating Crinetics Pharmaceuticals' daily price movement you should consider buying Crinetics Pharmaceuticals options at the current volatility level of 0.39%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Crinetics |
Crinetics Pharmaceuticals Option Chain
When Crinetics Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Crinetics Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Crinetics Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Crinetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Crinetics. It also shows strike prices and maturity days for a Crinetics Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | CRNX Option Call 16-01-2026 25 | 2 | 2026-01-16 | 31.0 - 36.0 | 35.0 | In |
Call | CRNX Option Call 16-01-2026 40 | 10 | 2026-01-16 | 21.5 - 26.5 | 19.36 | In |
Call | CRNX Option Call 16-01-2026 50 | 0 | 2026-01-16 | 0.0 - 0.0 | 17.0 | In |
Call | CRNX Option Call 16-01-2026 55 | 2 | 2026-01-16 | 12.0 - 17.0 | 13.91 | In |
Call | CRNX Option Call 16-01-2026 65 | 0 | 2026-01-16 | 0.0 - 0.0 | 12.0 | |
Call | CRNX Option Call 16-01-2026 70 | 5 | 2026-01-16 | 5.0 - 9.5 | 4.0 | Out |
Call | CRNX Option Call 16-01-2026 80 | 5 | 2026-01-16 | 4.0 - 9.0 | 2.63 | Out |
Put | CRNX Option Put 16-01-2026 25 | 0 | 2026-01-16 | 0.0 - 0.0 | 0.8 |
Crinetics Total Stockholder Equity
Total Stockholder Equity |
|
Crinetics Pharmaceuticals Corporate Management
| Jeff Knight | Chief Officer | Profile | |
| James Hassard | Chief Officer | Profile | |
| Adriana MBA | Chief Officer | Profile | |
| Gayathri Diwakar | Head Relations | Profile | |
| Dana MD | Chief Officer | Profile | |
| Robert MD | Senior Affairs | Profile |
Additional Tools for Crinetics Stock Analysis
When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.